Category: Expertise


Identifying Cardiogenic Shock Early with a Heart Team Approach

Dr. Alexander Truesdell, Interventional Cardiologist at Inova Heart and Vascular Institute discusses his editorial, the War on Shock, published in the Journal of Invasive Cardiology. The editorial compares his experience as a military physician with his experience as a cardiologist treating cardiogenic shock. Watch the video to learn which systems of care Dr. Truesdell suggests … Continue reading “Identifying Cardiogenic Shock Early with a Heart Team Approach”

Early Impella Support Associated with Increased Survival in Cardiogenic Shock

Key Takeaways

  • This retrospective study evaluated observational data of patients receiving either early or delayed initiation of Impella for the management of acute myocardial infarction complicated by cardiogenic shock (AMICS).
  • Receiving mechanical circulatory support (MCS) prior to percutaneous coronary intervention (PCI) compared with post-PCI initiation was associated with a higher survival rate to discharge among AMICS patients.
  • Overall survival to discharge for the cohort was 44%.
  • Additionally, early initiation of MCS at the first signs of shock and before inotropes, vasopressors, and PCI correlated with a higher rate of survival.
The use of mechanical circulatory support (MCS) in cardiogenic shock (CS) has been consistently shown to correlate with improved survival and assist interventionalists achieve complete revascularization.1,2,3 The use of MCS devices for the treatment of acute myocardial infarction complicated by cardiogenic shock (AMICS) may also provide hemodynamic support for some patients.4 Continue readingEarly Impella Support Associated with Increased Survival in Cardiogenic Shock

PCI vs CABG in Patients with Unprotected Left Main Coronary Artery Disease

Key Takeaways

  • This meta-analysis evaluated 6 randomized controlled trials to determine outcome differences between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) among patients with unprotected left main coronary artery disease ([ULMCAD] n = 4686).
  • Compared with CABG, PCI correlated with significantly lower rates of 30-day stroke (P = 0.007), death or MI (P = 0.04), or all-cause death, MI, or stroke (P = 0.01).
  • In the PCI group, there was a significantly lower rate of 30-day stroke incidence (P = 0.007) and all-cause death, MI, or stroke (P = 0.01).
  • The authors found no significant difference in outcomes at long-term follow-up (median 39 months) between the two groups.
Reference: Palmerini T et al. Am Heart J. 2017;190:54-63.
Continue readingPCI vs CABG in Patients with Unprotected Left Main Coronary Artery Disease

Case Review: High-Risk PCI Case Using Impella® Heart Pump Support on an Unprotected Left Main Coronary Artery

Dr. David Lasorda presents a high-risk PCI case using Impella® heart pump support to address an unprotected left main coronary artery with orbital atherectomy. Subscribe, tweet this or join the conversation by following us on Twitter: @ProtectedPCI. IM2-051-17 To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use … Continue reading “Case Review: High-Risk PCI Case Using Impella® Heart Pump Support on an Unprotected Left Main Coronary Artery”

Dr. Raja Hatem: Best Practices for Creating an Impactful PowerPoint Presentation

Dr. Raja Hatem has created more than 100 PowerPoint presentations. He explains how to make an impactful PowerPoint for presenting case reviews. IM2-052-17 To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/

Specialist Opinion: Updates on Detroit Cardiogenic Shock Initiative with Michael Hacala

Michael Hacala, Detroit Cardiogenic Shock (DCSI) Coordinator at Henry Ford Hospital. Tune in to hear updates about the program, and learn how to participate. Partnering hospital systems participating in DCSI use a defined protocol for early placement of Impella in patients in cardiogenic shock. Since July, initial results from a small sampling of 30 patients … Continue reading “Specialist Opinion: Updates on Detroit Cardiogenic Shock Initiative with Michael Hacala”

Specialist Opinion: Dr. Perwaiz Meraj

Dr. Perwaiz Meraj of Northwell Health discusses a new study demonstrating potential survival with Impella 2.5® heart pump insertion pre-PCI in heart attacks involving the left main coronary artery. IM2-049-17